Introduction
============

Right ventricular (RV) chamber is often involved in left ventricular (LV) pathologies as a consequence of a direct injury extension, afterload changes, or ventricular interdependence, which is mainly due to the close anatomic association between the two ventricles.[@bib1]

Over the last 50 years, awareness regarding the characterization of hypertrophic cardiomyopathy (HCM) has evolved dramatically in terms of phenotypic expression, pathophysiology, and clinical course.[@bib4] It is reasonable that the right ventricle may participate in the disease because of an extension of myopathic processes and/or because right and left ventricles share structurally hypertrophied interventricular septum.

At times, termed 'the forgotten ventricle', the right ventricle can prove difficult to accurately and reproducibly assess, as a result of its shape and volume dependency.[@bib3] Previous studies have shown an increased RV wall thickness and RV diastolic dysfunction in a large proportion of patients affected by HCM by using magnetic resonance imaging, 2D echocardiography, and biplane RV angiography.[@bib8] However, few data are presently available about RV regional and global modifications in this pathology.[@bib11]

Recent developments have improved cardiac function quantification and it seems that both magnitude and temporal sequence of tissue deformation can provide additional information in different cardiac diseases.[@bib13]

On this basis, the aim of the present study was to analyze the assorted involvement of RV myocardial function in HCM using 2D strain vector velocity imaging (VVI).

This is a novel feature tracking technique that uses myocardial speckle to assess cardiac mechanics. It uses an algorithm that automatically tracks motion of the tissue-cavity border and motion of reference points, showing tissue displacement, direction, and velocity. It also provides accurate information about segmental myocardial deformation during the cardiac cycle and has the additional advantage of assessing systolic and diastolic function of both ventricles independent of Doppler interrogation angle.[@bib14]

Patients and Methods
====================

Study population
----------------

### HCM group

Between January 2011 and December 2011, we prospectively included 100 HCM patients (age range: 8--77 years), who were referred to our echocardiographic laboratories for risk stratification. They were examined in a single centre (Yacoub Research Unite, Menoufiya University, Egypt). Patients were enrolled in the study after their informed consent, and approval of the Ethics Committee of Menoufiya University Hospitals was obtained.

The diagnosis of HCM was based on conventional echocardiographic demonstration of a non-dilated, hypertrophic LV ( ≥ 15 mm) in the absence of other cardiac or systemic diseases capable of producing the magnitude of hypertrophy evident.[@bib2] Exclusion criteria were diabetes mellitus, arterial hypertension, and evidence of coronary artery disease, atrial fibrillation, lung disease, and inadequate echocardiograms.

### Control group

We studied 33 age and sex-matched healthy subjects without detectable cardiovascular risk factor or receiving any medication. Volunteer controls were all selected from departments of pediatric and adult cardiology among subjects investigated for either sport or work eligibility.

### Conventional Echocardiography

Echocardiographic exams were performed with all subjects positioned in the left lateral decubitus, by the same operator (HM) in the parasternal long, short-axis, apical 2- & 4-chamber views using standard transducer positions. Esaote Mylab Gold 30 ultrasound system (Esaote S.p.A, Florence, Italy) equipped with a multi-frequency 2.5--3.5 MHz phased-array transducer was utilized.[@bib16] RV end diastolic diameter and wall thickness, LV end diastolic (LVEDD), end systolic diameter (LVESD), septum (SPT), posterior wall thickness (PWT), ejection fraction (EF%) and left atrial (LA) diameter & volume were all measured in accordance with the recommendations of the American Society of Echocardiography.[@bib18] The magnitude and extent of hypertrophy in both ventricles were assessed in all views. Color flow mapping and continuous-wave Doppler was used to define resting LVOT, mid cavity & RV obstruction, and to estimate pulmonary artery pressure (PAP) from tricuspid regurgitation velocity (Bernoulli equation). Peak early (E) and late (A) transmitral (E~m~ & A~m~) and trantricuspid (E~t~ & A~t~) filling velocities were measured from mitral and tricuspid inflow velocities. Peak systolic (S~a~), early diastolic (E~a~) and atrial diastolic (A~a~) velocity and isovolumetric relaxation time (IRT) were obtained by placing a tissue Doppler myocardial imaging (DMI) sample volume at the RVFW and lateral mitral annulus in the apical 4-chamber view. The E~m~/E~am~ and E~t~/E~at~ ratio were calculated.

Deformation imaging
-------------------

Border tracking of the left ventricle (LV) and right ventricle (RV) was manually traced in the recorded clips of apical 4C & 2C views, with good quality ECG signal and a frame rate between 40--70 fps. They were then stored for offline analysis using XStrain™ software. VVI is dedicated software that derives longitudinal myocardial velocity, strain (ϵ), strain rate (SR) and displacement from digitized 2D video clips. The endocardial border is automatically drawn at end diastole using a point-and-click approach. For RV it was tracked from the septal side of the tricuspid annulus to RV free wall side and for the LV from septal to lateral side of mitral annulus in apical 4C and from anterior to inferior side in the apical 2C. Velocity, ϵ, and SR, displacement graphics were automatically obtained[@bib17] ([Figure 1,2](#fig1 fig2){ref-type="fig"}).

Analysis of RV and LV deformation
---------------------------------

Longitudinal ϵ~sys~, systolic SR (SR~sys~), early diastolic (SR~e~), atrial diastolic (SR~a~) and post-systolic shortening (PSS) in the basal, mid and apical segments of RVFW and septum were measured. Global RV deformation was calculated from RVFW and septal segments. For LV deformation the same parameters were measured for basal, mid and apical segments of septal, lateral, anterior and inferior wall. To reduce random noise, each sample was obtained by averaging three consecutive heart cycles.

To estimate mechanical dyssynchrony, the index of myocardial systolic activation was calculated from regional strain curves for each ventricular segment, as a function of time from the beginning of Q-wave of ECG to the peak longitudinal systolic strain (TTP). RV and LV electromechanical delay was measured as the difference between TTP (d-TTP) in 6 RV and 12 LV segments respectively (difference between the longest and shortest times[@bib19]).

Intra-V dyssynchrony was defined as the standard deviation of the averaged time-to-peak-strain (TTP-SD). Inter-V dyssynchrony was estimated from TTP difference between the most delayed LV segment and RVFW.[@bib21]

Inter and Intra-observer variability
------------------------------------

Two independent observers performed two separate quantitative strain and strain rate analyses of RV and LV images, blindly, in 28 participants. Interobserver and Intraobserver agreement for ϵ~sys~ data was: (for LV ϵ~sys~, R = 0.87 and 0.94, for RV ϵ~sys~, R = 0.87 and 89, for TTP, R = 0.90 and 0.98, respectively) and SR~sys~ (interobserver R = 0.86, intraobserver R = 90). Both inter and intraobserver agreement were lower for diastolic SR (For SR~e~: R = 0.82 and 0.87, respectively) and (For SR~a~: R = 0.82 and 0.84, respectively).

Statistical analyses
--------------------

Data were presented as numbers (%) or mean ±  SD. The distribution of qualitative variables was analyzed by chi-square test or Fisher\'s exact test. Means of patients\' groups were compared by the unpaired Student test. Quantitative variables were correlated by the use of Pearson\'s correlation coefficient "r". All tests were 2-tailed and p value ≤ 0.05 was considered statistically significant. To identify significant independent predictors of global RV strain, variables that were statistically significant in univariate analysis were introduced in a multivariate regression model; the overall fitness of the model was evaluated with the calculation of the coefficient R ±  SE and its overall statistical significance was tested by ANOVA. Receiver operating characteristic (ROC) curve analysis was performed to select optimal cut-off values of clinical and echo measurements. The analysis was performed by the statistical software package IBM SPSS Statistics version 19.

Results
=======

Clinical characteristics of the study population
------------------------------------------------

Demographic and clinical characteristics of studied groups are outlined in [Table 1](#tbl1){ref-type="table"}. No differences were observed between HCM and control group in age, gender, BSA, heart rate or blood pressure. From 100 HCM patients (42% females), 71% were symptomatic (∼ 63% are NYHA class II, 35% class III, 2% class IV) and 8 (11%) had a history of syncope. 37 were familial-type (based on prospective evaluation of relatives), 16% had positive family history of premature sudden death, 79% had asymmetric septal hypertrophy, 18% had concentric LVH and 3% had apical HCM. 22 patients had extreme LVH (MWT ≥ 30 mm), 23% had LVOTO ≥  30 mmHg, 21% had RV apical trabecular hypertrophy, 4% had RV obstruction at mid & apical region, 49% had RV diameter\>30 mm, 3% had severe tricuspid regurgitation and 20% had PAP\>30 mmHg (range: 30--82 mmHg).

Conventional echocardiographic analysis
---------------------------------------

There was no significant difference among the two groups in LV EF%, RV diameter, E~m~ inflow velocity.

LA dimension, volume, SPT and LVPW thickness, LVM, LVMI and LVOT gradient, A~m~ inflow velocity, mitral IRT, tricuspid IRT, RVFW thickness were significantly greater, whereas LVESD, LVEDD, E~m~/A~m~ were significantly reduced in HCM group (p \< 0.001).

LV and RV end diastolic pressure as estimated by E~m~/E~am~ and E~t~/E~at~ ratios were significantly elevated in comparison to the control group (P \< 0.001, \< 0.01) respectively.

LV deformation analysis ([Table 2](#tbl2){ref-type="table"})
------------------------------------------------------------

In HCM, 2D strain analysis detected lower global and regional peak myocardial ϵ~sys~, SR~sys~ and SR~e~ (P \< .001) at the level of all analyzed segments in comparison to control

Despite the significant difference of SR~a~ at some segmental levels, the global atrial diastolic SR did not differ from the control. PSS within LV segments was exceedingly prevalent in HCM (57% vs 0% in control) and depicted in more than one segment (1.22 ± 1.56). Similarly, electromechanical delay was considerably prolonged in all LV segments, compared with its corresponding segments in healthy individuals (P \< .001). Intra-V dyssynchrony (TTP-SD) was significantly greater in HCM (63.9 ± 37.2) compared with control (29.2 ± 16.4) p \< 0.0001.

Regional and global RV deformation ([Table 3](#tbl3){ref-type="table"})
-----------------------------------------------------------------------

Both longitudinal ϵ~sys~ and SR values showed a base-to-apex gradient in the control group. RV deformation parameters showed a loss of this gradient and significant decline in HCM group. The averaged RVFW segments ϵ~sys~( − 14.7 ± 10.3 vs − 25.4 ± 2.9%) SR~sys~( − 1.12 ± 0.74 vs − 1.6 ± 0.53s^− 1^) and SR~e~ (0.95 ± 0.71 vs 1.69 ± 0.42 s^− 1^) were significantly reduced in the HCM group compared with control group (p \< 0.001 for each). These findings were also apparent in global RV deformation and gave similar significance (p \< 0.001) with the exception of atrial diastolic SR (P = Ns.).

For electromechanical delay between RV segments, controls showed homogeneous systolic activation of the ventricular walls. Conversely, the HCM group, despite the absence of intraventricular conduction defects by surface ECG, showed significant prolongation of TTP of all RV segments (p \< 0.001). Inter--V dyssynchrony was also verified and showed significant increase in HCM (68.2 ± 113 vs 24 ± 16 ms, p \< 0.001) compared with control group. PSS in RVFW was depicted in one or more segments in 30% of studied HCM series.

Univariate relations of RV 2D-strain indexes ([Table 4](#tbl4){ref-type="table"}, [Figures 3&4](#fig3 fig4){ref-type="fig"})
----------------------------------------------------------------------------------------------------------------------------

In HCM, the deformation variables estimated by RVFW were concordant with those derived by RV global assessment. RVFW and RV global strain strongly correlated with each other (r = 0.93, p \< 0.0001). Both were directly related to LV ϵ~sys~, SR~sys~ and SR~e~, EF%, RVFW displacement (p \< 0.001) and inversely related to age, positive family history (p \< 0.004, 0.005), RV wall thickness, MWT (p \< 0.0001), LV dyssynchrony (TTP-SD, p \< 0.0001), LA volume (p \< 0.0001), LVOT gradient (p \< 0.02, 0.005) LVESD (p \< 0.001, 0.002) and EDD (p \< 0.002, 0.03) respectively. Only global RV strain was negatively correlated to LVM, LVMI (p \< 0.01, 0.006) respectively. Conversely, RV regional and global strain were not linked to NYHA functional class, E~m~/E~am~ or E~t~/E~at~ ratios, PAP or PSS in this HCM series.

To explore the cutoff point that discriminate RV dysfunction we constructed ROC curves for RV ϵ~sys~, SR~sys~, SR~e~ and SR~a~ in HCM ([Figure 5](#fig5){ref-type="fig"}). For global and RVFW ϵ~sys~ − 19.5% shows 77, 70% sensitivity and 97% specificity respectively, AUC: 0.862 \[CI: 0.798--0.923, P \< .0001\]. Global and RVFW SR ~sys~ − 1.3% shows 82, 70 % sensitivity and 30% specificity with AUC 0.769 \[CI: 0.686--0.853, P \< .0001\]. For diastolic function; global and RVFW SR~e~, cutoff value 1.4 shows 91, 82% sensitivity and 92, 83% specificity respectively. In addition, Global SR~a~ 0.78 shows 81% sensitivity, 40% specificity, while RVFW SR~a~: 1.02 has 80% sensitivity& 40% specificity respectively. It seems that SR parameters were less specific than ϵ~sys~ in differentiation of RV dysfunction in HCM.

Multivariate analysis
---------------------

Stepwise, forward, multiple linear regression analyses were performed in the overall population to weigh the independent associations between global RV myocardial strain and LV phenotype. With this model, after adjusting for potential determinants, only global LV SR~sys~ (B coefficient = 5.9; IC at 95%: 3.06--8.75) and mean RVFW displacement (B coefficient − 0.9; CI at 95%: − 1.09 -- − 0.71) are independent predictors for global RV strain; p \< 0.0001. The model significantly explained the outcome variable (global RV strain), R ±  SE = 0.922 ± 2.96; p \< 0.0001.

Discussion
==========

Current research in clinical cardiac mechanics is moving from LV short axis and ejection fraction to long-axis function, and from global to regional deformation abnormalities in different myocardial diseases. Measurement of longitudinal strain (rate) in the RV can be regarded as a reliable measure for (global) RV myocardial function and ejection fraction, even more than in the LV, since 80% of total stroke volume is generated by longitudinal shortening.[@bib22]

This study with special focus on the RV provides new insights into mechanical alteration in the RV using feature tracking. Quantitative RV functional evaluation revealed a reduction in systolic and diastolic deformation, which is strongly correlated with LV phenotype in HCM. Global LV systolic strain rate and RVFW displacement was independent predictor to RV dysfunction. The most important finding of this study was that RVFW mechanics was closely related to global RV deformation and gave the same clinical correlates. The former might consequently be used as an alternative measure of RV pump function.

Previous experimental and clinical studies indicate that the septum is 'the lion of right ventricular function' and the fiber orientation and septal architecture & function is essential for RV ejection and suction for rapid filling.[@bib23] However, in the present study, despite septal hypertrophy and dysfunction due to involvement by myopathic process, the RVFW still playing important role in overall RV performance as its abnormal deformation was not only contributor but also representative to global RV deformation. Both RVFW and global RV longitudinal deformation was firmly parallel and were directly related to LV systolic and diastolic function and inversely related to familial type, magnitude of hypertrophy, severity of obstruction and LV dyssynchrony.

RV diastolic function
---------------------

In concordance with previous studies, we ascertained significantly lower early diastolic myocardial velocity and SR~e~ and increased IRT~t~, E~t~/E~at~ that reflects elevated right ventricular end-diastolic pressures (RVEDP) in comparison to the control, confirming a pattern of impaired RV filling. RV diastolic dysfunction was observed by Maeda et al.,[@bib24] who described impaired RV isovolumic relaxation by biplane RV angiography, and by Suzuki et al.[@bib25] who found lower early peak filling rate by magnetic resonance. Furthermore, in previous reports analyzing the RV Doppler inflow, Okamoto et al.[@bib26] and Lazzaret et al.[@bib27] described slow deceleration of rapid filling wave, increase in the lengthening of atrial contraction, and reduction of tricuspid E/A ratio. The present study verified RV myocardial diastolic dysfunction in HCM, since RV global ϵ~sys~ and regional 2D SR~e~ and SR~a~ peaks were significantly impaired, despite clinical evidence of RV failure is not exist.

RV function using feature tracking
----------------------------------

Integration of new evidence in basic science and evolutions in imaging technology must be matched with a new understanding of cardiac mechanics to provide insights into disease that can lead to new therapies.[@bib17]

Many of the recent efforts to assess RV function have used tissue velocity (Doppler) signals to assess velocity at the tricuspid annulus.[@bib22] Researchers have demonstrated the ability of DTI to characterize global and regional myocardial motion, or deformation, with high temporal resolution, but the angle dependency of Doppler, high noise-to-signal ratio and interobserver variability is an unavoidable limitation.[@bib21] Conversely, the alternative method for motion estimation proposed here is based on 2D feature tracking using VVI processing, a novel approach that is inherently 2D and independent of both cardiac translation and interrogation angle, as it tracks speckle patterns (acoustic markers) within serial B-mode sector scans.[@bib21]

RV global function as estimated by ϵ~sys~ determines the total amount of local deformation of RV wall segments, while SR which reflects the rate of myocardial deformation, developed by estimating the spatial gradients in myocardial velocities.

VVI echocardiography represents a simplified and angle-independent modality for quantification of regional RV and LV myocardial deformation. Longitudinal strain and strain rate are more sensitive in assessment of subclinical systolic and diastolic dysfunction of the heart.[@bib16] To the best of our knowledge, this is the first study to analyze RV regional deformation by the use of feature tracking VVI technology in patients affected by HCM.

RV function in hypertrophic cardiomyopathy
------------------------------------------

The current AHA classification of cardiomyopathies defines HCM as a disease with left and/or right ventricular hypertrophy, which is usually asymmetric and involves the interventricular septum.[@bib30]. Using cardiovascular MRI, Maron et al.[@bib18] demonstrated that morphological RV abnormalities are present in a substantial fraction of patients with HCM. In the current study 49% of our patient population had increased RV wall thickness, and 21% had RV apical trabecular hypertrophy. In a recent report by Morner et al.[@bib32] patients with HCM showed impaired global and regional RV tissue Doppler-derived myocardial performance index, with respect to healthy controls.

Similarly, the present study finds an RV and LV myocardial systolic and diastolic dysfunction at global and regional level using VVI and loss of base-to-apex gradient, despite normal LV ejection fraction and without evidence of clinical RV dysfunction.

Our results highlight a systolic asynchronicity involving the RV free wall and septum in HCM, the electromechanical delay between RV segments and prevalence of PSS and diminished RV myocardial deformation, which is not related to PAP, might be explained on the grounds of a direct involvement of RV wall by myopathic process.

On the other hand, the lower LV myocardial deformation indexes and its independent determination of RV dysfunction suggest ventricular interaction as further explanation of impairment in RV function in HCM. Ventricular interaction is an expression of close anatomic association between the two ventricles, which are encircled by common muscle fibres, share a septal wall, and are enclosed within the pericardium, and this is strengthened in our study by the close relation between deterioration of RV deformation and the magnitude of LV hypertrophy and aggressiveness of LV phenotype.

Interestingly, the present study cites the existence of extreme myocardial systolic non-uniformity and asynchrony in HCM, even in absence of intraventricular conduction delay. RV deformation was strongly related to intra-V asynchrony, which is the most powerful predictor of sudden cardiac death[@bib21] and provided significant incremental prognostic value according to previous studies.[@bib32] Such association between LV dyssynchrony and RV dysfunction could be part of a more critical phenotype and explain the increased risk of sudden cardiac death in HCM.

Additional longitudinal studies by 2D strain analyses are warranted to advance our understanding of the natural history of RV myocardial deformation in HCM, the extent of reversibility of RV dysfunction with medical therapy, and the possible long-term impact of such changes on patient outcomes.

Study limitation
================

Our study has several limitations. The first is that the feature tracking method is influenced by image quality; they can present limitations due to the physiological growth of the myocardial chambers, which prevents, sometimes, the perfect framing of the image in the echocardiographic window. The resolution of 2D imaging may be a problem in some subjects, and inadequate border recognition may be another factor limiting assessment of RV strain.

The second is that no analysis of gene mutation status was performed to offer further insight into genotype-phenotype relationships.

Finally, myocardial contractility is a complex mechanism; in the present study we investigated only the longitudinal deformation while the other components of wall deformation, like radial strain, circumferential are not included. However, approaching longitudinal myocardial function may be adequate, since 80% of total stroke volume is generated by longitudinal shortening. This better reflects myocardial function and may allow easier patient follow up in our daily practice.

Conclusion
==========

The impairment of RV myocardial deformation is evident in HCM using feature tracking. It is independently influenced by LV mechanics and correlated to the severity of LV phenotype. RV free-wall assessment of myocardial deformation and the results of RV global and regional involvement in HCM were comparable. Feature tracking, using this VVI approach, represents a promising and feasible non-invasive technique to provide more accurate analysis of regional function and uncover the subclinical RV involvement in HCM. The role of 2D strain imaging for stratifying the extent of myocardial abnormalities and future risk in HCM needs therefore further prospective evaluation.
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![**RV deformation analysis in apical 4C view**. The vectors show the direction of motion of any point selected on bottom left, on upper left color scale analysis of systolic strain, on the right side curves of Strain (ϵ~sys~) and SR of all selected points. **(A)**The mean ϵ~sys~ is − 22.9%, **(B)**SR~sys~ is − 1.63s^− 1^.](gcsp-2013-185-g001){#fig1}

![**LV deformation in apical 4C of same HCM patient**: **(A)** on the right side curves of Strain (ϵ~sys~) and SR of LV selected points. **(B)** RV longitudinal displacement (upper right) and transverse displacement (lower right).](gcsp-2013-185-g002){#fig2}

![Direct relation between RV free wall longitudinal strain (ϵ~sys~) and RV global strain in the HCM group.](gcsp-2013-185-g003){#fig3}

![Direct relation between RV global strain (ϵ~sys~) and global LV strain (ϵ~sys~) in HCM group.](gcsp-2013-185-g004){#fig4}

![ROC curve of global and RVFW deformation parameters has been plotted for differentiating HCM patients with RV dysfunction. (A) ϵ~sys~ global RV; (B) ϵ~sys~ RVFW; (C) SR~sys~ global RV; (D) SR~sys~ RVFW; (E) SR~e~ global RV; (F) SR~e~ RVFW; (G) SR~a~ global RV; and (H) SR~a~ RVFW.](gcsp-2013-185-g005){#fig5}

###### 

Clinical and conventional echocardiographic criteria.

  -----------------------------------------------------------------------
                         HCM (n = 100)   Control (n = 30)   P value^\*^
  ---------------------- --------------- ------------------ -------------
  Age (years)            41.1 ± 19.1     38.3 ± 8.6         Ns.

  Female sex             42 (42%)        7 (23%)            Ns.

  BSA                    1.8 ± 0.36      1.85 ± 0.16        Ns.

  Heart rate             74.6 ± 28.7     75.1 ± 9.9         Ns.

  SBP (mmHg)             130 ± 18.1      120 ± 9            Ns.

  DBP (mmHg)             84.2 ± 12.8     81 ± 6.5           Ns.

  LA diameter (mm)       37.4 ± 9.1      30.9 ± 4.6         0.001

  LA volume (ml)         63.8 ± 34.9     21.7 ± 8.7         0.001

  AoSD                   27.41+5.2       32.4 ± 3.61        0.001

  SAM (%)                20 (20%)                           

  LVOTO                  23 (23%)                           

  **Mitral regurge:**\   2 (2%)\         30 (100%)          Ns.
  no\                    35 (35%)\                          
  Trivial\               35 (35%)\                          
  Mild\                  21 (21%)\                          
  Moderate\              7 (7%)                             
  Severe                                                    

  LVESD (mm)             21.8 ± 6.5      33.2 ± 5.7         0.001

  LVEDD (mm)             36.1 ± 7.8      45.8 ± 6.7         0.001

  FS%                    40.6 ± 10       39.6 ± 8.6         Ns.

  EF%                    71.2 ± 11.5     64.4 ± 10.4        Ns.

  MWT (mm)               25.9 ± 7.1      9.9 ± 2.2          0.001

  SPT (mm)               24.6 ± 6.9      9.9 ± 2.2          0.001

  LVPW (mm)              14.4 ± 3.9      9.6 ± 2.1          0.001

  SPW ratio              1.81 ± 0.67     1 ± 0.21           0.001

  LVM (gm)               401 ± 188       197 ± 67           0.001

  LVMI (gm/m^2^)         222 ± 94        112.4 ± 32.6       0.001

  LVOTO (mmHg)           29 ± 44.1       2.96 ± 1.2         0.002

  Mitral E (m/sec)       0.86 ± 3.5      0.76 ± 0.13        Ns.

  Mitral A (m/sec)       1.27 ± 5.8      0.52 ± 0.13        0.001

  Mitral E/A             0.68 ± 0.62     1.2 ± 0.13         0.001

  DT (ms)                192 ± 70.5      140 ± 56           Ns.

  PAP (mmHg)             28.9 ± 16.3     12.3 ± 2.2         0.01

  Mitral IRT             93 ± 12.3       69.5 ± 7           0.001

  E~m~/E~am~             12 ± 7.7        6.2 ± 3.8          0.001

  E~t~/E~at~             10.5 ± 4.4      7.6 ± 3.2          0.01
  -----------------------------------------------------------------------

^\*^ Chi-Square test or Student\'s test. Ns.: non-significant, BSA: body surface area; SBP: systolic blood pressure; DBP: diastolic blood pressure, LVH: left ventricular hypertrophy, AoSD: aortic systolic diameter, SAM: systolic anterior motion, LVESD: left ventricular end-systolic diameter, LVEDD: left ventricular end-diastolic diameter, FS: fractional shortening, EF: ejection fraction, MWT: maximal wall thickness, LVPW: posterior wall thickness, SPT: septal thickness, LVM: left ventricular mass, LVMI: left ventricular mass index, LVOT: left ventricular outflow tract, DT: deceleration time, PAP: pulmonary artery pressure.

###### 

Left ventricular deformation parameters.

                                          HCM (n = 100)             Control (n = 30)         P value^\*^
  --------------------------------------- ------------------------- ------------------------ -------------
  ϵ~sys~ % septum                          − 11.7 ± 6.5              − 19.6 ± 1.9            0.001
  ϵ~sys~% lateral                          − 12.4 ± 7.4              − 19.95 ± 2.2           0.001
  ϵ~sys~ % anterior                        − 12.5 ± 9                − 19.6 ± 2              0.001
  ϵ~sys~% inferior                         − 11.5 ± 7.2              − 19.8 ± 2.3            0.001
  **ϵ** ~**sys**~% **global LV**          ** − 8.57** ** ± 6.8**    ** − 20.4** ** ± 1.1**   **0.001**
  PSS (%)                                 57 (57%)                  0                        
  PSS (no. of seg)                        1.22 ± 1.56               0                        
  Mean TTP (ms)                           407.1 ± 112               350.5 ± 33.1             0.001
  LV d-TTP                                189 ± 70                  92 ± 21                  0.001
  **TTP-SD**                              **63.9** ** ± 37.2**      **29.2** ** ± 16.4**     **0.001**
  SR~sys~ s^− 1^ septum                    − 0.74 ± 0.45             − 1.23 ± 0.35           0.001
  SR~sys~ s^− 1^ lateral                   − 0.79 ± 0.47             − 1.32 ± 0.19           0.001
  SR~sys~ s^− 1^ anterior                  − 0.76 ± 0.37             − 1.24 ± 0.33           0.001
  SR~sys~ s^− 1^ inferior                  − 0.78 ± 0.40             − 1.34 ± 0.20           0.001
  **SR** ~**sys**~ s^− 1^ **global LV**   ** − 0.78** ** ± 0.36**   ** − 1.3** ** ± 0.21**   **0.001**
  SR~e~ s^− 1^ septum                     0.7 ± 0.48                1.49 ± 0.47              0.001
  SR~e~ s^− 1^ lateral                    0.80 ± 0.56               1.61 ± 0.32              0.001
  SR~e~ s^− 1^ anterior                   0.85 ± 0.56               1.52 ± 0.46              0.001
  SR~e~ s^− 1^ inferior                   0.89 ± 0.47               1.64 ± 0.36              0.001
  **SR** ~**e**~ s^− 1^ **global LV**     **0.81** ** ± 0.54**      **1.57** ** ± 0.3**      **0.001**
  SR~a~ s^− 1^ septum                     0.45 ± 0.28               0.62 ± 0.12              0.002
  SR~a~ s^− 1^ lateral                    0.45 ± 0.31               0.61 ± 0.15              0.009
  SR~a~ s^− 1^ anterior                   0.46 ± 0.32               0.61 ± 0.13              0.012
  SR~a~ s^− 1^ inferior                   0.98 ± 4.68               0.63 ± 0.13              Ns.
  **SR** ~**a**~ s^− 1^ **global LV**     **0.59** ** ± 1.26**      **0.62** ** ± 0.11**     **Ns.**

^\*^ Student\'s test. Ns.: non-significant, **ϵ** ~**sys**~: peak systolic strain, LV: left ventricle, TTP: time to peak strain, TTP-SD: standard deviation of time to peak strain, SR~sys~: peak systolic strain rate, SR~e~: early diastolic strain rate, SR~a~: atrial diastolic strain rate.

###### 

Right ventricular regional and global deformation.

                                          HCM (n = 100)             Control (n = 30)          P value^\*^
  --------------------------------------- ------------------------- ------------------------- -------------
  RV diameter (mm)                        31 ± 6.35                 30.8 ± 5.87               Ns.
  RV thickness (mm)                       11.5 ± 6.35               6.3 ± 2.5                 0.001
  Tricuspid IRT                           80.2 ± 12                 59.4 ± 8.3                0.001
  TASV cm/s                               6.18 ± 3.75               9.69 ± 2.31               0.001
  TAEV cm/s                               4.63 ± 2.95               8.14 ± 2.23               0.001
  TAAV cm/s                               4.42 ± 2.72               5.99 ± 2.2                0.006
  ϵ~sys~ (%) basal RVFW                    − 19.0 ± 2.1              − 22.1 ± 5.02            0.04
  ϵ~sys~ (%) mid RVFW                      − 14.8 ± 12.4             − 26.7 ± 3.7             0.001
  ϵ~sys~ (%) apical RVFW                   − 7.3 ± 9.28              − 27.5 ± 4.2             0.001
  **ϵ~sys~** (%) **mean RVFW**            ** − 14.7** ** ± 10.3**   ** − 25.4** ** ± 2.9**    **0.001**
  **ϵ~sys~** (%) **global RV**            ** − 13.2** ** ± 7.3**    ** − 22** ** ± 1.73**     **0.001**
  PSS (%)                                 35 (35%)                  0                         
  PSS (no. of seg)                        0.51 ± 0.79               0                         
  TTP basal RVFW **(ms)**                 394 ± 139                 380 ± 33                  Ns.
  TTP mid RVFW **(ms)**                   400 ± 139                 332 ± 31                  0.001
  TTP apical RVFW **(ms)**                410 ± 160                 376 ± 31                  0.001
  RVFW mean TTP **(ms)**                  401 ± 137                 372 ± 30                  Ns.
  **TTP global RV (ms)**                  **395** ** ± 107**        **324** ** ± 25**         **0.001**
  **Inter-V dyssyn (ms)**                 **68.2** ** ± 113**       **24.2** ** ± 16.3**      **0.001**
  SR~sys~ s^− 1^ basal RVFW                − 1.1 ± 1.1               − 1.39 ± 0.66            Ns.
  SR~sys~ s^− 1^ mid RVFW                  − 1.09 ± 1.14             − 1.71 ± 0.56            0.005
  SR~sys~ s^− 1^ apical l RVFW             − 0.56 ± 0.63             − 1.97 ± 0.49            0.001
  **SR** ~**sys**~ s^− 1^ **Mean RVFW**   ** − 1.12** ** ± 0.74**   ** − 1.69** ** ± 0.53**   **0.001**
  **SR** ~**sys**~ s^− 1^ **global RV**   ** − 0.93** ** ± 0.46**   ** − 1.46** ** ± 0.31**   **0.001**
  SR~e~ s^− 1^ basal RVFW                 1.43 ± 1.17               1.74 ± 0.57               0.002
  SR~e~ s^− 1^ mid RVFW                   0.91 ± 0.9                1.62 ± 0.42               0.001
  SR~e~ s^− 1^ apical RVFW                0.52 ± 0.53               2.32 ± 0.41               0.001
  **SR** ~**e**~ s^− 1^ **mean RVFW**     **0.95** ** ± 0.71**      **1.69** ** ± 0.42**      **0.001**
  **SR** ~**e**~ s^− 1^ **global RV**     **0.83** ** ± 0.48**      **1.59** ** ± 0.32**      **0.001**
  SR~a~ s^− 1^ basal RVFW                 1.06 ± 0.91               1.33 ± 0.44               Ns.
  SR~a~ s^− 1^ mid RVFW                   1.59 ± 3.68               1.36 ± 0.29               Ns.
  SR~a~ s^− 1^ apical RVFW                0.39 ± 0.33               1.93 ± 0.37               0.001
  **SR** ~**a**~ s^− 1^ **mean RVFW**     **1.01** ** ± 2.95**      **1.11** ** ± 0.32**      **Ns.**
  **SR** ~**a**~ s^− 1^ **global RV**     **0.74** ** ± 1.51**      **0.86** ** ± 0.16**      **Ns.**
  Basal RVFW displac.                     10.2 ± 7.5                10.9 ± 3.27               Ns.
  Mid RVFW displac.                       4.03 ± 4.4                11.05 ± 2.59              0.001
  Apical RVFW displac.                    0.95 ± 2.54               12.4 ± 3.29               0.001
  mean RVFW displac.                      5.06 ± 3.97               10.8 ± 2.73               0.001

^\*^ Student\'s test. Ns.: non-significant, RV: right ventricle, RVFW: RV free wall, TAPSV: tricuspid annular systolic velocity, TAPEV: tricuspid annular plane early diastolic velocity, TAPAV: tricuspid annular plane atrial diastolic velocity, dyssyn: dyssynchrony, ϵ~sys~: peak systolic strain, LV: left ventricle, TTP: time to peak strain, TTP-SD: standard deviation of time to peak strain, SR~sys~: peak systolic strain rate, SR~e~: early diastolic strain rate, SR~a~: atrial diastolic strain rate, displac: displacement.

###### 

Correlation between global RV ϵ~SYS~% and RVFW ϵ~SYS~ and other clinical parameters.

  **global RV ϵ~sys~**   **ϵ** ~**SYS**~ **global LV**   **SR** ~**SYS**~ **global LV**   **SR~e~ global LV**   **SR~a~ global LV**   **RV diameter**   **RV thickness**   **MWT**      **LVOT gradient**   **Age**     **NYHA** **functional class**   **LV TTP-SD**     **LA volume**
  ---------------------- ------------------------------- -------------------------------- --------------------- --------------------- ----------------- ------------------ ------------ ------------------- ----------- ------------------------------- ----------------- ---------------
  r =                    0.748                           0.752                            0.664                  − 0.071              0.053             0.373               − 0.407     0.261                − 0.336    0.123                            − 0.427           − 0.351
  P                      0.0001                          0.0001                           0.0001                Ns.                   Ns.               0.0001             0.0001       0.004               0.0001      Ns.                             0.0001            0.0001
  RVFW ϵ~sys~ r =        0.641                           0.552                            0.503                  − 0.039              0.091             0.319               − 0.27      0.202                − 0.332    0.109                            − 0.418           − 0.229
  P                      0.0001                          0.0001                           0.0001                Ns.                   Ns.               0.0001             0.002        0.025               0.0001      Ns.                             0.0001            0.01
  **Global RV ϵ~sys~**   **EF%**                         **LVM**                          **LVMI**              **Et/Eta**            **PAP**           **DT**             **PSS LV**   **LVESD**           **LVEDD**   **RVFW** **displacement**       **RVFW ϵ~sys~**   **+ ve FH**
  r =                    0.25                             − 0.229                          − 0.242              0.202                 0.076              − 0.065            − 0.013      − 0.352             − 0.278    0.834                           0.932              − .27
  P                      0.005                           0.01                             0.006                 Ns.                   Ns.               Ns.                Ns.          0.0001              0.002       0.0001                          0.0001            0.004
  RVFW ϵ~sys~ r =        0.226                           0.137                            0.11                  0.154                 0.025              − 0.03             − 0.051      − 0.277             − 0.187    0.842                           1                  − .24
  P                      0.011                           Ns.                              Ns.                   Ns.                   Ns.               Ns.                Ns.          0.002               0.036       0.0001                                            0.005

RV: right ventricle, Ns.: non-significant, RVFW: RV free wall, ϵ~sys~: peak systolic strain, LV: left ventricle, SR~sys~: peak systolic strain rate, SR~e~: early diastolic strain rate, SR~a~: atrial diastolic strain rate, MWT: maximal wall thickness, LVOT: LV outflow tract, TTP-SD: SD of time to peak, LA: left atrium, EF: ejection fraction, LVMI: LV mass index, Et/Eta: tricuspid early Doppler inflow/tricuspid annular velocity, PAP: pulmonary artery pressure, DT: deceleration time, PSS: post systolic strain, LVESD: LV end systolic diameter, LVEDD: LV end diastolic diameter, + ve FH: positive family history.
